Authors
Latest:
How to Create an Engaging Specialty Pharmacy Clinical ProgramEffective clinical programs in specialty pharmacy encourage adherence and lead to superior treatment outcomes.
Latest:
Persistence Patterns Post Insulin Initiation in DiabetesThe number of patients who have from diabetes is expected to almost double from 285 million to 438 million people by 2030 due to obesity trends.
Latest:
"Right to Try" Legislation: A Developing Legal Issue Related to MedicationsIndividuals working in a health care field are often expected to have up-to-date information about the latest trends in laws and legislative changes related to their specialty.
Latest:
Controlling Diabetes: Teaching Patients to Take ChargeThe American Diabetes Association recommends that health care providers incorporate an estimated average glucose measurement when counseling patients with diabetes.
Latest:
Predictors of Healthcare Costs After Initiating Dabigatran Versus WarfarinThe study found no mean difference in all-cause healthcare costs for patients with newly diagnosed nonvalvular atrial fibrillation initiating treatment with dabigatran versus warfarin.
Latest:
Understanding the Beers Criteria Is EssentialThis medication list helps screen for and assess potentially inappropriate drugs to prevent adverse effects, hospitalization, and even death.
Latest:
Predictors of Response to Anti-Tumor Necrosis Factor Alpha Therapies in Rheumatoid ArthritisMethotrexate >15 mg weekly and adalimumab as first-line therapy were positive predictors of anti-TNF-a response in patients with rheumatoid arthritis.
Latest:
Increasing Vaccination Rates to Decrease Death RatesPharmacists were inducted into the world of immunizations about 20 years ago when they were first authorized to administer vaccines, making immunizations more accessible.
Latest:
Barriers to and Facilitators of Medication AdherenceThis study reports on barriers to and facilitators of medication adherence for asthma and diabetes patients who were both adherent and nonadherent to their medication regimen.
Latest:
Telepharmacy Offers Opportunity Amid PandemicThe contributions to patient care through the incorporation of digital clinical pharmacotherapy will help legitimize the role of pharmacists in telehealth.
Latest:
Closing Thoughts From The Panel On Pneumococcal VaccinationThe panel of pneumococcal vaccination experts offer their concluding insights and perspectives on the current landscape of pneumococcal vaccines.
Latest:
Variation in the Coverage of Disease-Modifying Multiple Sclerosis Drugs Among US PayersAn examination of payer coverage for multiple sclerosis drugs shows variation in how these drugs are covered and in the evidence that payers review to make these decisions.
Latest:
340B Recertification: Annual Opportunity to Ensure 340B Program ComplianceThe 340B Drug Pricing Program requires covered entities to ensure program integrity through several processes.
Latest:
Applying Value-Based Incentive Models Within Community Pharmacy PracticeHealthcare is transforming through new payment models, including value-based incentives (VBIs); this article discusses implementation principles and operational strategies for VBIs in community pharmacy practice.
Latest:
Assessing the Association Between Medication Adherence and Glycemic ControlAmong a population of adult patients with type 2 diabetes, adherence to oral hypoglycemic medications is independently associated with poor glycemic control, even after adjusting for patient-level covariates.
Latest:
Strategies to Overcome the Readmission Crisis in Health SystemsHealth care is in the midst of a transformation in which health care providers are increasingly being paid for value provided rather than per service.
Latest:
Lodoco: A New Indication for an Old DrugHistorically, colchicine has been used primarily in the management of gout; however, in 2023, the FDA approved Lodoco, a newly marketed colchicine product, for the management of cardiovascular disease.
Latest:
Viability of a Dose Optimization Program Within a Specialty PharmacyDose optimization strategies offer a potentially valid, clinically based intervention in which payers can realize a direct drug cost savings, and indirect medical cost avoidance.
Latest:
Oral Oncology: Utilization of Selected Oral Antineoplastic Enzyme Inhibitor AgentsAn overview of the utilization and cost for selected oral antineoplastic agents, with discussion regarding oncology in general, as well as the topic of adherence.
Latest:
Where Is Independent Pharmacy Headed?Several recent studies, blogs and articles have raised a question in my mind about how secure independant pharmacy practice is.
Latest:
The Farm Bill and Low-THC Hemp in IndianaIndiana’s chaotic hemp policy leaves consumers confused.
Latest:
Irritated About Your Irritable Bowels? Confronting Ulcerative ColitisThe symptoms of ulcerative colitis can cause embarrassment and pain, but pharmacists' expert advice can help ease the discomfort.
Latest:
Factors Associated With Employee Participation in a Value-Based Insurance Design InitiativeWe describe enrollment in a voluntary VBID initiative. Uptake was suboptimal, suggesting that barriers to enrollment may have significant implications for the overall effectiveness of VBID.
